Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT...

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY...

So, You’ve Become a Psychedelic-Informed Practitioner. Now what?

Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s...

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug...

PT445 – The Drug War, Harm Reduction, and the Middle Ground...

Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction...

Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

Introduction to Psychedelic Therapy and Career Pathways

Load more